Fresh Equities
ASX:CGB

ASX:CGB

CANN GLOBAL LIMITED

CANN GLOBAL LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

The Group’s primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets. Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group. The Group also retains an interest in its existing Bauxite Projects.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

24 Birriga Rd, Bellevue Hill NSW 2023, Australia

Pharmaceuticals
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Loading...


Directors


Announcements

All
All Time

Loading...


News

Loading...